中外医学研究2024，Vol.22Issue(27)：176-180,5.DOI:10.14033/j.cnki.cfmr.2024.27.045
中医药联合分子靶向治疗非小细胞肺癌研究进展
Research Progress on Molecular Targeted Therapy of Non-small Cell Lung Cancer Combined with Traditional Chinese Medicine
摘要
Abstract
Non-small cell lung cancer(NSCLC)is the most common type of lung cancer,and targeted therapy is the preferred treatment option for NSCLC.Despite significant progress in targeted drug therapy for NSCLC,there are still limitations due to tumor heterogeneity and tumor cell escape mechanisms.Therefore,more and more attention has been paid to the study of traditional Chinese medicine combined with targeted drug therapy in the treatment of NSCLC.This article summarizes the research on traditional Chinese medicine combined with targeted therapy in the field of NSCLC,in order to provide a theoretical basis for the combination therapy of traditional Chinese medicine and targeted therapy for NSCLC.关键词
靶向治疗/辨证论治/基因突变/血管内皮生长因子受体抑制剂Key words
Targeted therapy/Syndrome differentiation and treatment/Gene mutation/Inhibitor引用本文复制引用
张帆,朱玉龙..中医药联合分子靶向治疗非小细胞肺癌研究进展[J].中外医学研究,2024,22(27):176-180,5.基金项目
新疆维吾尔自治区天山创新团队计划项目(2023D14004) （2023D14004）
"天山英才"-青年科技拔尖人才项目(2022TSYCCX0028) （2022TSYCCX0028）
